Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

(1R,2S,5R)-Menthyl-(2R,5S)-5-(4-Amino-2-Oxo-2H-Pyrimidin-1-Yl)-[1,3]Oxathiolane-2-Carboxylic Acid

    • Product Name (1R,2S,5R)-Menthyl-(2R,5S)-5-(4-Amino-2-Oxo-2H-Pyrimidin-1-Yl)-[1,3]Oxathiolane-2-Carboxylic Acid
    • Alias Menthyl d4T
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    205514

    Iupac Name (1R,2S,5R)-menthyl-(2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]oxathiolane-2-carboxylic acid
    Molecular Formula C19H28N4O4S
    Molecular Weight 408.52
    Cas Number 192725-50-1
    Appearance White to off-white solid
    Solubility Slightly soluble in water, soluble in organic solvents like methanol and DMSO
    Smiles CC1CCC(C(C)C)C(C1)OC(=O)[C@@H]2O[C@@H](SC2)n3ccnc(N)c3=O
    Inchi InChI=1S/C19H28N4O4S/c1-10-4-5-15(9-11(10)2)17(3)7-6-16(17)27-18(25)14-13(26-19(14)28-15)23-8-12(20)21-5-24(23)22/h4-5,11,13-14,16,19H,6-7,9,20H2,1-3,8H3/t11-,13+,14-,16+,17-,18-,19-/m1/s1
    Chirality Multiple chiral centers (1R,2S,5R and 2R,5S)
    Storage Conditions Store at -20°C, protected from light and moisture
    Usage Intermediate for the synthesis of antiviral nucleoside analogues

    As an accredited (1R,2S,5R)-Menthyl-(2R,5S)-5-(4-Amino-2-Oxo-2H-Pyrimidin-1-Yl)-[1,3]Oxathiolane-2-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing A 10-gram sample is provided in a sealed, amber glass bottle with a tamper-evident cap, labeled with product details and hazard warnings.
    Shipping The chemical `(1R,2S,5R)-Menthyl-(2R,5S)-5-(4-Amino-2-Oxo-2H-Pyrimidin-1-Yl)-[1,3]Oxathiolane-2-Carboxylic Acid` is shipped in secure, airtight containers, compliant with hazardous material regulations. Temperature control and protective packaging ensure stability, with express courier services for expedited delivery and tracking. Full documentation accompanies all shipments for customs and safety compliance.
    Storage Store **(1R,2S,5R)-Menthyl-(2R,5S)-5-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]oxathiolane-2-carboxylic acid** in a cool, dry, and well-ventilated area, tightly sealed in a light-resistant container. Keep away from moisture, heat, and incompatible substances. Refrigerate at 2–8°C, if recommended, and protect from light. Follow appropriate safety protocols and local regulatory guidelines for handling and disposal.
    Application of (1R,2S,5R)-Menthyl-(2R,5S)-5-(4-Amino-2-Oxo-2H-Pyrimidin-1-Yl)-[1,3]Oxathiolane-2-Carboxylic Acid

    Applications of (1R,2S,5R)-Menthyl-(2R,5S)-5-(4-Amino-2-Oxo-2H-Pyrimidin-1-Yl)-[1,3]Oxathiolane-2-Carboxylic Acid in Industrial Manufacturing

    As a dedicated chemical raw material manufacturer, we supply (1R,2S,5R)-Menthyl-(2R,5S)-5-(4-Amino-2-Oxo-2H-Pyrimidin-1-Yl)-[1,3]Oxathiolane-2-Carboxylic Acid to a select group of industrial sectors that require precise chiral intermediates in advanced synthesis routes. Below we detail the principal application fields where our product is integrated into high-value downstream processes, specifying regulatory frameworks, formulation ratios, incorporation stages, and the types of end products our clients produce.

    1. Antiviral Nucleoside Analogues Production

    Pharmaceutical manufacturers utilize this oxathiolane carboxylic acid as a critical chiral intermediate in the synthesis of antiviral nucleoside analogues. The compound allows for stereochemically controlled construction of nucleoside core structures, essential for obtaining the active pharmaceutical ingredients (APIs) used in various antiviral therapies. Downstream production requires stringent chiral purity and quality consistency throughout multiple synthesis steps, especially when scaling from pilot to commercial quantities.

    Industry compliance standards

    • ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • US FDA 21 CFR Part 211
    • EU EudraLex Volume 4, Part II (API GMP)
    • Relevant monographs in USP, EP, JP as applicable for corresponding APIs

    Typical usage ratio

    • Typically 1.1–1.8 equivalents per nucleobase unit, adjusted according to the targeted nucleoside analogue and stoichiometry of the coupling reaction

    Downstream process integration

    • Introduced during enantioselective coupling with protected nucleobases, followed by deprotection and further functionalization to construct the nucleoside scaffold

    Final product types

    • Antiviral pharmaceutical intermediates
    • Finished antiviral APIs such as lamivudine and related compounds
    • Bulk nucleoside analogues for formulation into oral, injectable, and topical antiviral medications

    2. Active Pharmaceutical Ingredient (API) Contract Manufacturing

    Custom synthesis organizations and large-scale contract manufacturers use this material as a core intermediate for developing specific APIs targeting hepatitis and HIV treatments. The compound’s chiral architecture plays a decisive role during key nucleoside condensation reactions, ensuring the enantiomeric excess required by global regulatory authorities for finished dose forms. Rapid, reproducible synthesis is essential for meeting batch production targets in this segment.

    Industry compliance standards

    • US FDA DMF (Drug Master File) requirements
    • ICH Q11: Development and Manufacture of Drug Substances
    • PIC/S Guide to Good Manufacturing Practice for Medicinal Products
    • WHO Prequalification for API sources

    Typical usage ratio

    • 0.95–1.25 equivalents per API structure, with adjustments based on yield optimization and molar requirements for multi-step synthesis routes

    Downstream process integration

    • Utilized in the core nucleoside coupling stage, followed by chromatographic purification and API crystallization prior to downstream micronization or granulation

    Final product types

    • Pharmaceutical drug substances (APIs) delivered in bulk for formulation
    • High-purity intermediates shipped under GMP for regulatory submissions
    • Custom API variants for new drug application (NDA) filings

    3. Pharmaceutical Research and Development Synthesis

    Specialty labs and pharmaceutical R&D centers depend on this compound for chiral route design and the exploration of novel nucleoside candidates. Its unique stereochemistry supports early-stage feasibility studies, route scouting, and process optimization for both preclinical candidates and new patented antiviral drugs. Researchers closely monitor the enantiopurity and compatibility within library build-outs, requiring consistent supply and analytical support.

    Industry compliance standards

    • GLP (Good Laboratory Practice) for preclinical research
    • ISO 17025 for analytical laboratory processes
    • Internal quality audit protocols for pharmaceutical discovery projects
    • Material transfer agreements and chain of custody for research samples

    Typical usage ratio

    • Variable: 0.5–3.0 equivalents depending on target molecule and reaction scaling from milligram to multi-gram pilot batches

    Downstream process integration

    • Entered at nucleobase addition or late-stage modifications within rapid iterative synthetic cycles, often coupled with high-throughput screening workstations

    Final product types

    • Novel nucleoside scaffolds for antiviral or anticancer lead discovery
    • Reference standards for process validation and analytical methods
    • Non-GMP intermediates for proof-of-concept studies

    4. Fine Chemical Intermediates Manufacturing

    Our clients in the fine chemical sector use this oxathiolane-derived acid as a starting material when building blocks with defined stereochemistry are necessary for further elaboration. These products feed into advanced molecules for the pharmaceutical, biotech, and diagnostic reagent markets, especially when highly regulated supply chains must guarantee source verification and quality traceability across complex global operations.

    Industry compliance standards

    • ISO 9001-certified quality management systems
    • REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) compliance for the EU market
    • Custom specifications agreed per client-supplier technical agreements
    • Hazard Communication Standard (HCS) – OSHA 29 CFR 1910.1200 for US shipments

    Typical usage ratio

    • 1.0 equivalent as a core synthetic fragment, with excess adjustments up to 1.3 equivalents to maximize conversion in batch or continuous flow settings

    Downstream process integration

    • Fed as an initial coupling component or late-stage fragment in modular synthetic assemblies, purified through chromatographic or crystallization procedures suitable for downstream diversification

    Final product types

    • Chiral fine chemical intermediates
    • Precursor molecules for diagnostic reagent kits
    • Custom specialty chemicals for use in advanced material science research
    Free Quote

    Competitive (1R,2S,5R)-Menthyl-(2R,5S)-5-(4-Amino-2-Oxo-2H-Pyrimidin-1-Yl)-[1,3]Oxathiolane-2-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    (1R,2S,5R)-Menthyl-(2R,5S)-5-(4-Amino-2-Oxo-2H-Pyrimidin-1-Yl)-[1,3]Oxathiolane-2-Carboxylic Acid: A Closer Look from the Manufacturer’s Perspective

    Direct Commitment: What Real Chemical Manufacturing Means

    Production of advanced fine chemicals stands as both craft and discipline. Every day at our plant, raw materials pass through tightly controlled environments, moving step by step under the attention of seasoned process chemists and vigilant operators. Over the years, (1R,2S,5R)-Menthyl-(2R,5S)-5-(4-Amino-2-Oxo-2H-Pyrimidin-1-Yl)-[1,3]Oxathiolane-2-Carboxylic Acid has taken a steady role in our manufacturing lineup. Our focus leans into real-world, bench-to-bulk manufacturing, not repackaging or relabeling material from third parties. Our experience in hands-on production drives choices in upstream raw material screening, analytical testing, scaling, and routine troubleshooting as we deliver each batch.

    Purpose: Where This Product Makes a Difference

    On the factory floor, people respect this compound for its relevance in nucleoside analog synthesis. This is not just another molecular structure on a certificate of analysis, but a precision tool in the toolbox of antiviral and pharmaceutical discovery. The menthyl substitution strengthens chiral purity and brings benefits in downstream steps. Colleagues in R&D tell us that clean, well-defined precursors like this save weeks in route development and help maintain confidence in clinical pipeline stability. From our perspective, providing a reliable source of this oxathiolane carboxylic acid means scientists can spend fewer hours troubleshooting impurities and more hours chasing breakthroughs.

    Specifications Shaped by Real-World Demands

    Manufacturing this carboxylic acid revolves around careful control of stereoselectivity and purity. Each lot moves through automated reaction monitors and calibrated analytical platforms that our team maintains with regular standards. Chiral HPLC and NMR form the spine of our release tests, not just to meet documentation guidelines, but because quality fluctuates where you cut corners. Our process technicians monitor crystallizations, solvent exchanges, and chromatographic separations firsthand, responding to small shifts in yield or color before any batch leaves the plant. Material that does not match agreed specs never heads for a drum or a bottle.

    In full-scale operation, moisture and trace metal contamination become the real challenge. We learned early that small traces from leaky valves or inferior solvent lines can create expensive headaches downstream. Today, every reactor and filter that touches this product receives routine inspection from our internal maintenance crew. We keep records on actual interventions, not just planned schedules. This habit shows in low variability across production campaigns. Since our company handles each production run start-to-finish, there’s accountability if something goes off script—no shifting blame down the supply chain.

    Key Differences: Beyond Commodity Sourcing

    We hear feedback from global partners who used to buy generic versions of this intermediate. Their teams often encountered unpredictable batch variability or the slow creep of hard-to-remove process impurities. These differences carry consequences: crystallizations that stall, final yields that drop, and chromatographic purifications that become bottlenecks for research. Our investments in plant upgrades, hands-on analytic method development, and repetitive operator training grow out of this direct feedback. Each process tweak we make links to a real pain point raised by chemists, not some abstract marketing proposal.

    Our batches ship with traceable production records. Customers know they will receive the same batch if they place another order the following month, not a replacement from another factory across the ocean. Our barcoding and documentation keep materials connected to their origins without relying on paperwork chasing across continents. When a customer flags a question about what solvent was used, or whether a certain impurity ever cropped up below reporting limits, our quality assurance team can pull records and resolve it the same week. This kind of traceability matters more than warehouse shelf-talkers or third-party certificates.

    Applications from R&D to Industrial Manufacturing

    Chemical innovation relies on consistency. Downstream use of (1R,2S,5R)-Menthyl-(2R,5S)-5-(4-Amino-2-Oxo-2H-Pyrimidin-1-Yl)-[1,3]Oxathiolane-2-Carboxylic Acid covers a broad spectrum—preparation of nucleoside analogs, library expansion for screening, and scalable pilot manufacturing. Researchers and pilot plant chemists often use our product in the first steps of nucleoside backbone assembly. Here, reaction kinetics shift if micro-impurity levels change, so those using our material report easier method transfer and less time spent on ad hoc clean-up. We see our product’s impact amplified at scale: clinical lots hinge on reproducible chiral purity and low residual solvents, factors that become far more significant as campaigns stretch over months.

    On our end, we pay close attention to the product lifecycle. This compound bridges the sensitive space between discovery-scale synthesis and full cGMP manufacture. Every pilot lot we deliver impacts the integrity of final drug substance, especially as companies move toward commercial launch. Our approach embraces routine feedback loops with end users, which in turn helps us refine purification strategies, sometimes integrating small changes (for example, the level of crystalline hydrate) that correlate with downstream conversion yields in customer processes.

    Quality Anchored in Daily Operations

    Many promises in this industry depend on paper. Our team believes that a reliable supplier must prove value by practice, not brochures. We operate our analytical chemistry lab next to the production suite, not in a separate building or contracted out to external labs. Instruments see routine use and are calibrated by our in-house chemists. This proximity shortens cycle times and strengthens our ability to resolve issues as they emerge, for instance, if a specific impurity profile looks different midway through a run.

    Risk lives in the details. By managing every control point with real-time oversight, small deviations can be corrected before they escalate. Teams document interventions as they occur, which helps ensure reproducibility and backs up batch documentation. Stakeholders in QA, QC, and production attend the same daily production meetings, catching quality signals early so later steps benefit from a single team’s vigilance. This cross-functional transparency creates confidence for users up the supply chain.

    Consistent Scaling: Moving Lab Protocols to Kilogram Production

    Chemists sometimes underestimate the challenge of scaling up asymmetric syntheses. What works fine in two-gram batches on the bench can go sideways at ten kilograms. Common issues include irregular crystallizations, unexpected emulsions, and product sticking to vessel walls. We approach scaling as both art and science: engineers collaborate with process chemists to model each stage. For this carboxylic acid, we optimized temperature ramps and stirring rates after seeing late-stage product dropout on scaled-up runs. Sharing learnings between campaigns, and feeding back real production numbers into new cycles, let us reduce yield loss by a measurable margin.

    We are direct witnesses to the value of batch-to-batch reproducibility. Repeat orders do not compel us to adjust processes on the fly or swap out different starting materials. Because we operate as the producer—never as a repackager—raw materials, intermediates, solvents, and reagents align tightly with previous runs. The impact for users: validation data on their side becomes meaningful, and transfer to regulatory submission proceeds without unexpected hiccups.

    Regulatory, Safety, and Documentation as Product Features

    In markets demanding regulatory compliance, simple purity does not suffice. Audit readiness reflects the reality of manufacturing, not just in chemical content but traceability and data management. Every step in our process, from quarantine sampling to lot release, undergoes regular review against both internal policies and up-to-date best practices. Documentation follows the product, with electronic and hard-copy records readily available for customer review or regulatory inspection.

    Trust builds with familiarity and openness. Real manufacturers welcome plant tours and sample audits because oversight only strengthens process reliability. By making technical support available from the lab bench itself, rather than a distant call center unfamiliar with daily operations, we offer context if end users encounter questions. Product stewardship becomes more than a slogan; operators and chemists take responsibility for every drum or container carrying our name out into the world.

    Environmental and Waste Management Realities

    Sustainable chemical manufacturing means confronting challenges beyond the lab notebook. Handling organosulfur intermediates and sensitive chiral precursors generates waste streams that demand respect. Our team invests regularly in filtration, solvent recycling, and energy monitoring hardware. Each improvement reduces the environmental footprint of a kilogram produced. Principled disposal practices, verified through internal auditing, keep our manufacturing aligned with both government guidelines and community standards.

    Waste minimization requires tight batch control and process engineering discipline. Poor process control leads to off-spec material that must be discarded—wasteful both environmentally and financially. By learning from every campaign, and feeding process data back into our control systems, we’ve seen tangible reductions in solvent discharge and overall material use. These are hard-won gains, measured not just in spreadsheets but in the day-to-day work of plant technicians and engineers, whose recommendations take precedence over hollow green-marketing promises.

    Continuous Improvement: Living Practice, Not Buzzword

    Real operational excellence arises from continuous learning, not as an empty slogan but as a culture practiced every day. Feedback from chemists, operators, and external partners shapes how our process evolves. On several occasions, customer labs uncovered minor impurities using advanced analytical tools. These discoveries prompted us to re-examine our own protocols and, in some cases, upgrade purification stages or adjust final container selection. Instead of blaming “storage conditions” or “shipping environments,” we change what’s under our direct control.

    We share comparative data with long-term partners as a regular habit, comparing not just COA statistics but actual yields, chromatographic profiles, and even subjective process notes. This transparency creates room for collaborative problem-solving—when one group reports an unusual result, production and QC teams come together to troubleshoot and document lessons for every department. Improvement emerges from collective experience, not from one-size-fits-all “standard operating procedures.”

    Why Origin Matters: Supply Chains and Direct Accountability

    Routine news of supply chain disruptions or unexpected regulatory holds brings added attention to product origin. We respond with open documentation and site-level traceability: if someone questions where this acid was produced, we do not point to warehouse locations or third-party brokers. We point to the line on our own plant floor and the batch logs maintained by the team who worked the shift. Facility access and process logs connect directly to each batch shipped.

    Downstream users—especially in regulated or clinical programs—know real risk enters when intermediates from unknown or shifting sources are used. Direct, proven manufacturing means fewer questions from auditors and fewer surprises in critical process steps. We do not hand off issues to “partner plants” or outsource quality to contractors. End-to-end ownership underpins reliability.

    Trust Built on Real Experience

    The world of advanced chemical intermediates continues to grow more complex each year. Sourcing quality products depends on more than bullet points on a sales sheet. It involves confidence built up batch after batch, reinforced by the willingness to invite scrutiny, share data, and accept responsibility for outcomes. Since our company’s early days, we’ve learned lessons not from corporate consultants but from the heat of real production campaigns, when everything has to work and excuses mean missed delivery and lost business.

    Operators, chemists, and QA staff draw on years of hands-on experience—the most valuable guarantee backing every lot we ship. They handle (1R,2S,5R)-Menthyl-(2R,5S)-5-(4-Amino-2-Oxo-2H-Pyrimidin-1-Yl)-[1,3]Oxathiolane-2-Carboxylic Acid not as a line item, but as a daily responsibility. This habit cannot be copied by companies trading in labels or marketing soundbites. Customers looking for partnership discover it matters where their material actually comes from—and who stands behind it.

    Final Perspective: The Manufacturer’s Role in Progress

    The movement of advanced intermediates from synthesis to real-world impact depends on direct relationships between producers and users. As real manufacturers, we recognize the responsibility that comes with delivering such a pivotal precursor. Our equipment, people, and protocols all echo the same goal: not merely to supply a molecule, but to enable progress, one reaction at a time, with all the care, vigilance, and pride that comes from being the true source.